BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20585866)

  • 1. Metaplastic breast cancer: to radiate or not to radiate?
    Tseng WH; Martinez SR
    Ann Surg Oncol; 2011 Jan; 18(1):94-103. PubMed ID: 20585866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metaplastic Breast Cancer: Practice Patterns, Outcomes, and the Role of Radiotherapy.
    Haque W; Verma V; Naik N; Butler EB; Teh BS
    Ann Surg Oncol; 2018 Apr; 25(4):928-936. PubMed ID: 29322287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
    Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
    Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database.
    Li Y; Chen M; Pardini B; Dragomir MP; Lucci A; Calin GA
    J Transl Med; 2019 Sep; 17(1):318. PubMed ID: 31547814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different outcomes between breast-conserving surgery plus radiotherapy and mastectomy in metaplastic breast cancer: A population-based study.
    Xia LY; Xu WY; Hu QL
    PLoS One; 2021; 16(9):e0256893. PubMed ID: 34473783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
    Nelson RA; Guye ML; Luu T; Lai LL
    Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.
    Yu P; Liu P; Zou Y; Xie X; Tang H; Li N; Xie X; Ye F
    Cancer Med; 2020 Aug; 9(15):5381-5391. PubMed ID: 32515157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.
    Fields EC; DeWitt P; Fisher CM; Rabinovitch R
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):747-52. PubMed ID: 24138917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas.
    Paul Wright G; Davis AT; Koehler TJ; Melnik MK; Chung MH
    Ann Surg Oncol; 2014 Oct; 21(11):3497-503. PubMed ID: 24838367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radiation therapy and survival for adenoid cystic carcinoma of the breast.
    Sun JY; Wu SG; Chen SY; Li FY; Lin HX; Chen YX; He ZY
    Breast; 2017 Feb; 31():214-218. PubMed ID: 27915203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished survival in patients with inner versus outer quadrant breast cancers.
    Gaffney DK; Tsodikov A; Wiggins CL
    J Clin Oncol; 2003 Feb; 21(3):467-72. PubMed ID: 12560437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
    Kruper L; Kauffmann RM; Smith DD; Nelson RA
    Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database.
    Ong CT; Campbell BM; Thomas SM; Greenup RA; Plichta JK; Rosenberger LH; Force J; Hall A; Hyslop T; Hwang ES; Fayanju OM
    Ann Surg Oncol; 2018 Aug; 25(8):2249-2260. PubMed ID: 29855830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients.
    Zhang J; Yang C; Lei C; Zhang Y; Ji F; Gao H; Yang M; Zhang L; Li J; Zhu T; Li W; Zhuang X; Wang K
    Breast; 2021 Aug; 58():10-17. PubMed ID: 33878598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.
    Martinez SR; Tseng WH; Shah DR; Canter RJ; Bold RJ
    Med Oncol; 2012 Sep; 29(3):1523-8. PubMed ID: 21983860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era.
    Beal SH; Martinez SR; Canter RJ; Chen SL; Khatri VP; Bold RJ
    Med Oncol; 2010 Dec; 27(4):1420-4. PubMed ID: 20049562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
    Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
    Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.